Immunome, Inc.IMNMNASDAQ
Loading
Year-over-year gross profit growth rate
| Period | Value |
|---|---|
| Q4 2025 | 98.42% |
| Q3 2025 | -1592.96% |
| Q2 2025 | 12.61% |
| Q1 2025 | 6.87% |
| Q4 2024 | -5.91% |
| Q3 2024 | 23.10% |
| Q2 2024 | 129.74% |
| Q1 2024 | -73.11% |
| Q4 2023 | 12.56% |
| Q3 2023 | 333.93% |
| Q2 2023 | 6.20% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |